Free tool
FAERS Monitor: Combivir
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 020857 or its brand name (Combivir, Lamivudine, Zidovudine). Reports on generic versions are filed under their own applications.
Reports
7,705
Serious
6,925
90% of reports
Hospitalization
2,264
Death reported
595
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug exposure during pregnancy1,147
- foetal exposure during pregnancy720
- pain601
- anxiety568
- emotional distress557
- anhedonia504
- anaemia453
- abortion spontaneous443
- maternal exposure during pregnancy381
- premature baby363
- chronic kidney disease327
- pyrexia285
- stillbirth278
- nausea270
- osteoporosis269
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 503 |
| 2005 | 614 |
| 2006 | 564 |
| 2007 | 506 |
| 2008 | 479 |
| 2009 | 522 |
| 2010 | 664 |
| 2011 | 373 |
| 2012 | 401 |
| 2013 | 298 |
| 2014 | 332 |
| 2015 | 469 |
| 2016 | 245 |
| 2017 | 179 |
| 2018 | 266 |
| 2019 | 332 |
| 2020 | 339 |
| 2021 | 277 |
| 2022 | 184 |
| 2023 | 52 |
| 2024 | 49 |
| 2025 | 21 |
| 2026 | 18 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,046,454 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| stillbirthSignal | 278 | 166.6 | 147.9 | 42,984 |
| drug exposure during pregnancySignal | 1,147 | 95.3 | 90.2 | 103,442 |
| anhedoniaSignal | 504 | 53.4 | 49.0 | 25,376 |
| premature babySignal | 363 | 33.3 | 30.1 | 11,225 |
| abortion spontaneousSignal | 443 | 30.5 | 27.9 | 12,499 |
| foetal exposure during pregnancySignal | 720 | 24.4 | 22.7 | 16,044 |
| osteoporosisSignal | 269 | 18.0 | 16.0 | 4,273 |
| emotional distressSignal | 557 | 12.6 | 11.6 | 5,951 |
| chronic kidney diseaseSignal | 327 | 11.8 | 10.6 | 3,218 |
| maternal exposure during pregnancySignal | 381 | 11.7 | 10.6 | 3,723 |
| anaemiaSignal | 453 | 6.5 | 5.9 | 2,115 |
| anxietySignal | 568 | 5.5 | 5.0 | 2,087 |
| painSignal | 601 | 2.7 | 2.5 | 646 |
| pyrexiaSignal | 285 | 2.2 | 2.0 | 200 |
| nausea | 270 | 0.9 | 0.8 | 1 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.